Lineage Cell Therapeutics, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $6.5M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $3.8M | 58.6% |
| Other | $2.7M | 41.4% |
| Net Cash Flow | $0 | 0.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $6.5M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $3.8M | 58.6% |
| Other | $2.7M | 41.4% |
| Net Cash Flow | $0 | 0.0% |